Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 140.28-4.4613.37610.65-249.43

What is the latest EBIT Growth ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Growth ratio of SOTAC PHARMACEUTICALS is 140.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025140.28
Mar2024-4.46
Mar202313.37
Mar2022610.65
Mar2021-249.43

How is EBIT Growth of SOTAC PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 140.28
Positive
Mar2024 -4.46
Negative
Mar2023 13.37
-97.81
Mar2022 610.65
Positive
Mar2021 -249.43 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹122.7 Cr -3.9% -18.9% -10.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-3.9%

-18.9%

-10.8%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses